What does DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG do?

DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG is a specialist medical practice in Oosterzele. Private Limited, started on 21 April 2011, 2 establishments.

What is the address of DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG?

The registered office of DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG is located at Tramstraat 45, 9860 Oosterzele.

Is DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG still active?

Yes. According to the CBE (15 November 2026) DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG is active, legal situation “Normale toestand”, started on 21 April 2011.

Is DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG registered on Peppol?

Yes, DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG is registered on the Peppol network with ID 0208:0836006574.

What is the enterprise number of DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG?

The enterprise number of DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG is BE0836006574.

When was DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG founded?

DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG was founded on 21 April 2011.

Who are the directors of DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG?

According to the 2025 annual accounts, the directors of DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG are: Paul Meuleman.

Is DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 April 2011; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG make in 2025?

DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG posted a profit after taxes of € 544,722 in financial year 2025.

What is the revenue of DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG?

As a small company, DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 709,355.

DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG (Private Limited)

Dossier DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG, printed on 15 November 2026 from databakkes.be/en/0836006574/dokter-paul-meuleman-klinisch-bioloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG from Oosterzele, company number BE0836006574, closed financial year 2025 with a result of € 544,722 after tax. For that financial year DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG recorded a gross margin of € 709,355 and equity of € 3.1 million. Compared with financial year 2024, the result moved from € 611,596 to € 544,722. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 7, 2026.

What it is worth Growing

€ 3.1 million

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 544,722

▼ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 420,571

▲ 39% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 310,568 paid out

57 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 4,941

▼ 65% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,280

▼ 23% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 54,472

▼ 11% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 801,207 Gross margin 2022: € 801,207 First fiscal year in the series	€ 644,203 Gross margin 2023: € 644,203 ▼ 20% vs 2022 (€ 801,207) Unfavourable step	€ 789,656 Gross margin 2024: € 789,656 ▲ 23% vs 2023 (€ 644,203) Favourable step	€ 709,355 Gross margin 2025: € 709,355 ▼ 10% vs 2024 (€ 789,656) Unfavourable step	▼ 10%
Profit after taxes	€ 500,285 Profit after taxes 2022: € 500,285 First fiscal year in the series	€ 441,451 Profit after taxes 2023: € 441,451 ▼ 12% vs 2022 (€ 500,285) Unfavourable step	€ 611,596 Profit after taxes 2024: € 611,596 ▲ 39% vs 2023 (€ 441,451) Favourable step	€ 544,722 Profit after taxes 2025: € 544,722 ▼ 11% vs 2024 (€ 611,596) Unfavourable step	▼ 11%
Equity	€ 2,393,031 Equity 2022: € 2,393,031 First fiscal year in the series	€ 2,614,597 Equity 2023: € 2,614,597 ▲ 9% vs 2022 (€ 2,393,031) Favourable step	€ 2,905,338 Equity 2024: € 2,905,338 ▲ 11% vs 2023 (€ 2,614,597) Favourable step	€ 3,139,492 Equity 2025: € 3,139,492 ▲ 8% vs 2024 (€ 2,905,338) Favourable step	▲ 8%
Total debts	€ 259,765 Total debts 2022: € 259,765 First fiscal year in the series	€ 258,105 Total debts 2023: € 258,105 ▼ 1% vs 2022 (€ 259,765) Favourable step	€ 286,928 Total debts 2024: € 286,928 ▲ 11% vs 2023 (€ 258,105) Unfavourable step	€ 283,385 Total debts 2025: € 283,385 ▼ 1% vs 2024 (€ 286,928) Favourable step	▼ 1%
Cash	€ 654,717 Cash 2022: € 654,717 First fiscal year in the series	€ 312,064 Cash 2023: € 312,064 ▼ 52% vs 2022 (€ 654,717) Unfavourable step	€ 302,424 Cash 2024: € 302,424 ▼ 3% vs 2023 (€ 312,064) Unfavourable step	€ 420,571 Cash 2025: € 420,571 ▲ 39% vs 2024 (€ 302,424) Favourable step	▲ 39%
Retained profit	€ 2,380,631 Retained profit 2022: € 2,380,631 First fiscal year in the series	€ 2,602,197 Retained profit 2023: € 2,602,197 ▲ 9% vs 2022 (€ 2,380,631) Favourable step	€ 2,892,938 Retained profit 2024: € 2,892,938 ▲ 11% vs 2023 (€ 2,602,197) Favourable step	€ 3,127,092 Retained profit 2025: € 3,127,092 ▲ 8% vs 2024 (€ 2,892,938) Favourable step	▲ 8%
Dividend	€ 274,982 Dividend 2022: € 274,982 First fiscal year in the series	€ 219,885 Dividend 2023: € 219,885 ▼ 20% vs 2022 (€ 274,982) Unchanged	€ 320,855 Dividend 2024: € 320,855 ▲ 46% vs 2023 (€ 219,885) Unchanged	€ 310,568 Dividend 2025: € 310,568 ▼ 3% vs 2024 (€ 320,855) Unchanged	▼ 3%
Balance sheet total	€ 2,652,797 Balance sheet total 2022: € 2,652,797 First fiscal year in the series	€ 2,872,702 Balance sheet total 2023: € 2,872,702 ▲ 8% vs 2022 (€ 2,652,797) Unchanged	€ 3,192,267 Balance sheet total 2024: € 3,192,267 ▲ 11% vs 2023 (€ 2,872,702) Unchanged	€ 3,422,877 Balance sheet total 2025: € 3,422,877 ▲ 7% vs 2024 (€ 3,192,267) Unchanged	▲ 7%

By gross margin, DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG ranks 1st of 19 companies with main activity “Activiteiten van medisch specialisten” in Oosterzele that publish figures (fiscal year 2025).

Key figures of DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

Ask about DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG?

What happened at DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 7, 2026 New annual accounts for financial year 2025: profit of € 544,722 (▼ 11% vs 2024). Source: NBB ↗
May 4, 2011 New establishment in Oosterzele. KBO
May 4, 2011 New establishment in Oudenaarde. KBO
2011 Paul Meuleman became a director. NBB
Apr 21, 2011 Start of the company according to the CBE. KBO

In short

From € 500,285 profit in 2022 to € 544,722 profit in 2025.

Paid € 930,311 in corporate taxes since 2022.

Best year ever: 2024, with € 611,596 profit.

Paid out € 1.1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Paul Meuleman

DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG

Behind DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG is Paul Meuleman.

Directors

According to the 2025 annual accounts

Paul Meuleman

Director

since 2011

Establishments

Establishment units

Physical locations of this company

Registered office

Tramstraat 45

9860 Oosterzele

2.199.183.208

Minderbroedersstraat 3

9700 Oudenaarde

Active since 4 May 2011

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Oosterzele

Same main activity (Activiteiten van medisch specialisten), 19 active companies in Oosterzele, largest first.

BDC-RAD

€ 582,658 gross margin · 2025

Drs. Depaepe-Latoir

€ 537,438 gross margin · 2025

Dokterspraktijk Dr. B. Van Vlem

€ 447,876 gross margin · 2025

Dokter Nathalie Van Belle - Anesthesist

€ 389,434 gross margin · 2025

Dr. Katrien Wierckx, endocrinologie

€ 388,057 gross margin · 2025

DR. S. SUYKENS - ANESTHESIOLOGIE

€ 380,510 gross margin · 2025

All companies with this activity → Largest companies in Oosterzele →

Details

Company number

0836.006.574

VAT number

BE 0836.006.574

Registered office

Tramstraat 45, 9860 Oosterzele

Names & denominations

DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

21 April 2011

Peppol

Active · Active since 19 Oct 2025

Activities · NACE

Activiteiten van medisch specialisten

Activiteiten van medische beeldvorming en medische laboratoria

Activiteiten van medische laboratoria

View on CBE Public ↗ Annual accounts (NBB) ↗

DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG

Financials

Ask about DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG the way you would ask their accountant.

What happened to DOKTER PAUL MEULEMAN - KLINISCH BIOLOOG?

Management

Directors

Establishments

Establishment units

Similar companies in Oosterzele

Details

Frequently asked questions